Clinical Trial Update: Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes [NA]

View source ↗

Summary

This terminated clinical trial compared morning-only, evening-only, and twice-daily insulin glargine in people with type 1 diabetes, with results posted in 2017…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Type 1 Diabetes, Hypoglycemia | NA | Status: TERMINATED | Results posted: 2017-06-29